10-Gingerol Suppresses Osteoclastogenesis in RAW264.7 Cells and Zebrafish Osteoporotic Scales
Overview
Authors
Affiliations
Osteoporosis is the most common aging-associated bone disease and is caused by hyperactivation of osteoclastic activity. We previously reported that the hexane extract of ginger rhizome [ginger hexane extract (GHE)] could suppress receptor activator of nuclear factor kappa-B ligand (RANKL)-induced osteoclastogenesis in RAW264.7 cells. However, the anti-osteoclastic components in GHE have not yet been identified. In this study, we separated GHE into several fractions using silica gel column chromatography and evaluated their effects on osteoclastogenesis using a RAW264.7 cell osteoclast differentiation assay () and the zebrafish scale model of osteoporosis (). We identified that the fractions containing 10-gingerol suppressed osteoclastogenesis in RAW264.7 cells detected by tartrate-resistant acid phosphatase (TRAP) staining. In zebrafish, GHE and 10-gingerol suppressed osteoclastogenesis in prednisolone-induced osteoporosis regenerated scales to promote normal regeneration. Gene expression analysis revealed that 10-gingerol suppressed osteoclast markers in RAW264.7 cells [osteoclast-associated immunoglobulin-like receptor, dendrocyte-expressed seven transmembrane protein, and matrix metallopeptidase-9 ()] and zebrafish scales [osteoclast-specific cathepsin K (CTSK), , and ]. Interestingly, nuclear factor of activated T-cells cytoplasmic 1, a master transcription regulator of osteoclast differentiation upstream of the osteoclastic activators, was downregulated in zebrafish scales but showed no alteration in RAW264.7 cells. In addition, 10-gingerol inhibited CTSK activity under cell-free conditions. This is the first study, to our knowledge, that has found that 10-gingerol in GHE could suppress osteoclastic activity in both and conditions.
Osteoporosis: Causes, Mechanisms, Treatment and Prevention: Role of Dietary Compounds.
Stromsnes K, Martinez Fajardo C, Soto-Rodriguez S, Kajander E, Lupu R, Pozo-Rodriguez M Pharmaceuticals (Basel). 2025; 17(12.
PMID: 39770539 PMC: 11679375. DOI: 10.3390/ph17121697.
Bioactive Compounds in Osteoarthritis: Molecular Mechanisms and Therapeutic Roles.
Maouche A, Boumediene K, Bauge C Int J Mol Sci. 2024; 25(21).
PMID: 39519204 PMC: 11546619. DOI: 10.3390/ijms252111656.
Gingerol-zinc complex loaded 3D-printed calcium phosphate for controlled release application.
Chaudhari V, White B, Dahiya A, Bose S Drug Deliv Transl Res. 2024; 15(4):1317-1329.
PMID: 39179707 DOI: 10.1007/s13346-024-01677-9.
Zang L, Saitoh S, Katayama K, Zhou W, Nishimura N, Shimada Y Dis Model Mech. 2024; 17(5).
PMID: 38747698 PMC: 11152558. DOI: 10.1242/dmm.050438.
A mechanistic review of chinese medicine polyphenols on bone formation and resorption.
Li Y, Li L, Li X, Luo B, Ye Q, Wang H Front Pharmacol. 2022; 13:1017538.
PMID: 36313339 PMC: 9597080. DOI: 10.3389/fphar.2022.1017538.